PATENT CLAIM ANALYSIS

Application Number: 15919923
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "356000"]

Abstract:
Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.

Claim (Index 4):
The pharmaceutical composition of  claim 1 , wherein the calcium channel blocker is amlodipine, nifedipine, diltiazem, nimodipine, verapamil, isradipine, felodipine, nicardipine, nisoldipine, clevidipine, dihydropyridine, lercanidipine, nitrendipine, cilnidipine, manidipine, mibefradil, bepridil, barnidipine, nilvadipine, gallopamil, lidoflazine, aranidipine, dotarizine, diproteverine, or the pharmaceutically acceptable salt or hydrate thereof.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 90.0
- Lexical Diversity: 1.16
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15352425', '13766266', '14079464', '13799682', '13205545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7872933982483391
- 35 USC 102 Novelty (BERT): 0.5718657240916563
- Combined Prediction Score: 0.7657506308326708
- Mean Citation Score: 347.9151060000001
- Max Citation Score: 484.78262
- Similarity Product: 368.0262648839068

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test